PT-141

PT-141, also known as bremelanotide, is a synthetic cyclic peptide listed by QURE as a 10mg research material. The two names identify the compound in different contexts: PT-141 is the familiar research designation, while bremelanotide is used in chemical and scientific references.

The molecule belongs to the family of peptide structures related to alpha-melanocyte-stimulating hormone. Its ring-containing architecture distinguishes it from linear peptide chains. Chemical identity depends on the full structure, including terminal groups, rather than simply the number of amino acid residues.

PT-141 is closely related structurally to Melanotan II, but it is not the same compound. In particular, the terminal acid and amide distinction is relevant when comparing their chemical records. One name should not be substituted for the other in material documentation.

This listing is for QURE’s research product, not a finished pharmaceutical formulation. The stated 10mg quantity does not establish a prepared concentration, route of use, or equivalence to another commercial preparation.

For product review, match the compound name and selected amount with the documentation available for that material. The COA library is the central index for current reports. No therapeutic benefit, clinical suitability, or particular laboratory outcome is represented by this description.

For research use only. Not for human or veterinary use, consumption, or administration.